Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
11
92%
Ph phase_2
1
8%

Phase Distribution

11

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
11(91.7%)
Phase 2Efficacy & side effects
1(8.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(6)
Other(6)

Detailed Status

unknown6
Completed6

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 111 (91.7%)
Phase 21 (8.3%)

Trials by Status

unknown650%
completed650%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_1

The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells

NCT05207995
unknownphase_1

Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells

NCT05214014
unknownphase_1

Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells

NCT05187104
unknownphase_1

Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells

NCT05520112
unknownphase_1

Treatment of Alopecia Using Follicular Stem Cells

NCT05210452
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05207995Phase 1

The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells

Completed
NCT05214014Phase 1

Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells

Unknown
NCT05187104Phase 1

Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells

Unknown
NCT05520112Phase 1

Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells

Unknown
NCT05210452Phase 1

Treatment of Alopecia Using Follicular Stem Cells

Unknown
NCT05108077Phase 1

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Unknown
NCT05186883Phase 1

Treatment of Postoperative Hypoparathyroidism Using Cultured Allogenic Parathyroid Cells

Unknown
NCT04382547Phase 1

Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells

Completed
NCT04426643Phase 1

Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells

Completed
NCT04184258Phase 1

Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells

Completed
NCT04184232Phase 2

Treatment of Recurrent Bladder Cancer With Dendritic Cells

Completed
NCT04446884Phase 1

Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells

Completed

All 12 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
12